Old Web
English
Sign In
Acemap
>
Paper
>
A493 Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM) (PX-171-004)
A493 Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM) (PX-171-004)
2009
Ravi Vij
M. Wang
Robert Z. Orlowski
Alexander Keith Stewart
S Jagannath
Vishal Kukreti
J Taylor
D Fuhrman
Scott Cruickshank
R Schwartz
Lori Kunkel
David Siegel
Keywords:
Immunology
Carfilzomib
Cancer research
Medicine
Phases of clinical research
Internal medicine
Pathology
Oncology
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]